Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Altimmune, Inc. - Common Stock
(NQ:
ALT
)
2.830
+0.030 (+1.07%)
Streaming Delayed Price
Updated: 11:02 AM EDT, May 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Altimmune, Inc. - Common Stock
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Looking Into Altimmune's Return On Capital Employed
↗
March 03, 2023
Via
Benzinga
Earnings Outlook For Altimmune
↗
February 27, 2023
Via
Benzinga
Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week
↗
February 16, 2023
Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week.
Via
The Motley Fool
4 Analysts Have This to Say About Altimmune
↗
January 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
January 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
January 13, 2023
Via
Benzinga
7 Small-Cap Stocks with Big Growth Potential in 2023
↗
January 10, 2023
Some of the greatest investment opportunities can be found in these top small-cap stocks to buy in the new year.
Via
InvestorPlace
Altimmune Touts Encouraging Data From Fatty Liver Disease Study
↗
December 20, 2022
Via
Benzinga
Recent Selloff Is A 'Buying Opportunity' For This NASH Stock, Says Analyst
↗
September 16, 2022
Via
Benzinga
Expert Ratings for Altimmune
↗
September 16, 2022
Analysts have provided the following ratings for Altimmune (NASDAQ:ALT) within the last quarter:
Via
Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
↗
December 21, 2022
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical...
Via
Benzinga
Lucid Group, Verona Pharma And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
↗
December 20, 2022
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
↗
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
↗
December 18, 2022
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
↗
December 01, 2022
Via
Benzinga
My 3 Top Biotech Stock Picks for 2023
↗
November 22, 2022
Biotech stocks are set to shine in 2023.
Via
The Motley Fool
What 4 Analyst Ratings Have To Say About Altimmune
↗
September 16, 2022
Over the past 3 months, 4 analysts have published their opinion on Altimmune (NASDAQ:ALT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
↗
September 26, 2022
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Via
Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
↗
September 23, 2022
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day...
Via
Benzinga
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
↗
September 15, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.
Via
Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
↗
September 15, 2022
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.
Via
Benzinga
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
↗
September 14, 2022
Via
Benzinga
Dow, S&P 500 Turn Lower; Altimmune Shares Slide
↗
September 14, 2022
U.S. stocks pared gains toward the end of trading, with the Dow Jones dropping around 80 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 14, 2022
Via
Benzinga
Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session
↗
September 14, 2022
Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.
Via
Benzinga
Nasdaq Surges 100 Points; Crude Oil Rises 2%
↗
September 14, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Wednesday.
Via
Benzinga
Twilio (TWLO) Stock Gains 6% on Layoff News
↗
September 14, 2022
Twilio (TWLO) stock is rising on Wednesday after the programmable communication tools company revealed plans to lay off employees.
Via
InvestorPlace
Nucor, Altimmune And Some Other Big Stocks Moving Lower On Wednesday
↗
September 14, 2022
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Wednesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Altimune (ALT) Stock Plummets 33% Despite Positive Clinical Data
↗
September 14, 2022
Altimune (ALT) stock is falling hard on Wednesday even after reporting positive results from a Phase 1b clinical trial this morning.
Via
InvestorPlace
US Stocks Open Higher, Producer Prices Decline for 2nd Month
↗
September 14, 2022
U.S. stocks traded higher this morning, following the release of PPI data for August.
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
